National Health Act (Pharmaceutical Benefits Early Supply) Amendment May 2013 specification under subsection 84AAA(2) (No. PB 28 of 2013) (Cth)
COMMONWEALTH OF AUSTRALIA
Instrument number PB 28 of 2013
National Health Act (Pharmaceutical Benefits – Early Supply) Amendment May 2013 - specification under subsection 84AAA(2)1
Amendment determination under subsection 84AAA(2) of the National Health Act 1953
I, Karen Binnekamp, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 22 April 2013
KAREN BINNEKAMP
Acting Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment determination — Pharmaceutical Benefits - Early Supply
1 Name of Instrument
(1) This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment May 2013 - specification under subsection 84AAA(2).
(2) This Instrument may also be cited as No. PB 28 of 2013.
2 Commencement
This Instrument commences on 1 May 2013.
3 Amendment of PB 30 of 2009
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009- specification under subsection 84AAA(2), PB 30 of 2009.
Schedule 1 Amendments
Schedule 1, item dealing with Cimetidine
Omit from the columns in the order indicated:
| Tablet 800 mg | Oral | 30 | 5 |
Schedule 1, after item dealing with Temozolomide, capsule 140 mg
insert in the columns in the order indicated:
| Capsule 180 mg | Oral | 5 | 5 |
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.
See
0
0
0